BioXcel Therapeutics, Inc. (BTAIQ)
OTCMKTS · Delayed Price · Currency is USD
0.042919
-0.030981 (-41.92%)
At close: Sep 8, 2026

BioXcel Therapeutics Statistics

Total Valuation

BTAIQ has a market cap or net worth of 1.34 million. The enterprise value is 92.95 million.

Market Cap1.34M
Enterprise Value 92.95M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

BTAIQ has 31.31 million shares outstanding. The number of shares has increased by 389.70% in one year.

Current Share Class 31.31M
Shares Outstanding 31.31M
Shares Change (YoY) +389.70%
Shares Change (QoQ) +28.55%
Owned by Insiders (%) 0.62%
Owned by Institutions (%) 8.28%
Float 26.89M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.81
PB Ratio -0.01
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 125.27
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.21

Current Ratio 0.21
Quick Ratio 0.09
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -2.05
Interest Coverage -2.60

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -102.43%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 41.28%
Weighted Average Cost of Capital (WACC) 12.93%
Revenue Per Employee 25,586
Profits Per Employee -2.44M
Employee Count29
Asset Turnover 0.03
Inventory Turnover 0.70

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -98.87% in the last 52 weeks. The beta is 0.19, so BTAIQ's price volatility has been lower than the market average.

Beta (5Y) 0.19
52-Week Price Change -98.87%
50-Day Moving Average 0.81
200-Day Moving Average 1.33
Relative Strength Index (RSI) 19.47
Average Volume (20 Days) 17,671,679

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.54

Income Statement

In the last 12 months, BTAIQ had revenue of 742,000 and -70.86 million in losses. Loss per share was -3.15.

Revenue 742,000
Gross Profit 394,000
Operating Income -44.73M
Pretax Income -70.86M
Net Income -70.86M
EBITDA -44.51M
EBIT -44.73M
Loss Per Share -3.15
Full Income Statement

Balance Sheet

The company has 12.84 million in cash and 104.45 million in debt, with a net cash position of -91.61 million or -2.93 per share.

Cash & Cash Equivalents 12.84M
Total Debt 104.45M
Net Cash -91.61M
Net Cash Per Share -2.93
Equity (Book Value) -115.46M
Book Value Per Share -3.69
Working Capital -108.45M
Full Balance Sheet

Cash Flow

Operating Cash Flow -50.90M
Capital Expenditures n/a
Depreciation & Amortization 225,000
Net Borrowing -8.41M
Free Cash Flow -50.90M
FCF Per Share -1.63
Full Cash Flow Statement

Margins

Gross Margin 53.10%
Operating Margin -6,028.57%
Pretax Margin -9,549.87%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BTAIQ does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -389.70%
Shareholder Yield -389.70%
Earnings Yield -5,273.89%
FCF Yield -3,788.62%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on February 10, 2025. It was a reverse split with a ratio of 0.0625.

Last Split Date Feb 10, 2025
Split Type Reverse
Split Ratio 0.0625

Scores

BTAIQ has an Altman Z-Score of -45.8 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -45.8
Piotroski F-Score 3